tirzepatide sibo Treatment Los Angeles | Small Intestinal Bacterial Overgrowth Why I Take Low-Dose Tirzepatide
Description
Russell, M
Patients who remain on lower doses may not experience the full appetite-suppressing effects needed for continued weight loss
However, this approach is off-label and not supported by clinical trial data
All the analyses were performed using SAS
The company received FDA approval for Mounjaro to treat Type 2 diabetes in adults in May 2022 following a priority review
